Search the Newsreel

Dynatrace (DT) Could Be 36% Undervalued Following AI Demand And Mixed Guidance

Datronix Sets Board Meeting to Approve Interim Results and Consider Dividend

(PATK) Volatility Zones as Tactical Triggers

Patrick Industries Inc. (NASDAQ: PATK) shows stable neutral readings in shorter horizons, potentially easing a long-term weak bias. The AI models have generated three distinct trading strategies: a Position Trading Strategy, a Momentum Breakout Strategy, and a Risk Hedging Strategy, each tailored for different …

ETFs Investing in Viatris, Inc. Stocks

This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold Viatris, Inc. (VTRS) stocks, sorted by market value. It details various ETFs, including their issuer, management style, focus, expense ratio, assets under management (AUM), and 3-year NAV total return. The ETFs …

LCI Industries advances merger with Patrick amid HSR review

LCI Industries (LCII) is moving forward with its merger with Patrick Industries, a two-step transaction announced on June 30, 2026. Both companies filed Hart-Scott-Rodino premerger notification forms, and the deal's completion depends on the expiration of the HSR waiting period and other closing conditions. …

Why Is Patronus Resources (ASX:PTN) Back in Focus?

Patriot Resources Secures Key Community Access for Tassa Silver-Gold Work

Viatris Inc. (VTRS) Stock Price, News, Quote & History

This Yahoo Finance page provides a comprehensive overview of Viatris Inc. (VTRS) stock, including its current price, dividend information, and a collection of recent news articles. The news highlights Viatris's Q2 earnings performance, strategic moves like selling Tyrvaya, and analyst insights on its valuation …

Atrium Therapeutics (Nasdaq:RNA) - Stock Analysis

This Simply Wall Street analysis provides an overview of Atrium Therapeutics (Nasdaq:RNA), a biopharmaceutical company focused on RNA therapeutics for cardiomyopathies. The report highlights the company's recent FDA clearance for its investigational new drug ATR 1072 for PRKAG2 syndrome, its Q1 2026 earnings exceeding …

AtriCure (NASDAQ:ATRC) Sets New 12-Month High - Here's Why

AtriCure (NASDAQ:ATRC) reached a new 52-week high of $43.18, trading above its 50-day and 200-day moving averages. The company reported strong quarterly earnings, exceeding revenue estimates with $153.6 million and $0.18 EPS. Despite significant institutional ownership, insiders have sold shares totaling $1.78 million in …

ATRC: Strong growth, innovation, and clinical trial catalysts drive robust financial and market expansion

AtriCure, Inc. (ATRC) is experiencing strong growth and profitability, maintaining leadership in AFib and pain management. The company's financial performance is bolstered by innovation and operational leverage, with significant clinical trials expected to expand market opportunities. Free cash flow will be directed towards organic …

(MEGI) Volatility Zones as Tactical Triggers

This article provides an AI-generated analysis of Mainstay Cbre Global Infrastructure Megatrends Term Fund (NASDAQ: MEGI), identifying neutral near and mid-term readings that could moderate a long-term positive bias. It details an exceptional 16.5:1 risk-reward short setup and outlines three distinct institutional trading strategies …

Benchmark cuts Patrick Industries stock price target on lower shipment volumes

Benchmark has lowered its price target for Patrick Industries (NASDAQ:PATK) from $135 to $115, while maintaining a Buy rating, due to reduced shipment volumes in the recreational vehicle and manufactured housing sectors. The stock is currently trading near its 52-week low and has seen …

MATRIMONY: Q1 FY27 net profit jumped 127% year-over-year on double-digit revenue growth and margin expansion

Gayatri Highways amends HKR Roadways stake sale agreement

What's Going On With CEMATRIX Corporation Stock Tuesday?

Understanding the Setup: (KIDS) and Scalable Risk

This article provides an in-depth analysis of Orthopediatrics Corp. (NASDAQ: KIDS), highlighting a potential long-term breakout if current strong sentiment holds. It offers AI-generated signals, institutional trading strategies tailored to different risk profiles, and a multi-timeframe signal analysis to guide investors. Key findings indicate …

Patrick Industries files HSR notifications for proposed LCI mergers

Patrick Industries (PATK) has filed Hart-Scott-Rodino notifications regarding its planned two-step merger to acquire LCI Industries. This action follows a merger agreement where LCI will become a wholly owned subsidiary of Patrick Industries. The completion of the mergers is contingent upon the expiration or …

MATRIMONY: PAT up 127% YoY, double-digit growth in revenue and billing, strong Q2 outlook

Earnings call transcript: Matrimony.com Q1 2026 profit jumps 127% as stock rises 10%

Atrium Mortgage Investment Corp AI Earnings Miss Estimates by 4.0%

Matrimony.com consolidated net profit rises 127.14% in the June 2026 quarter

Matrimony.com Q1 Results: Net profit surges 127% YoY to ₹190.8 lakh

Datronix Narrows Interim Loss but Issues Profit Warning

MATRIMONY: Revenue and profit rose sharply year-over-year, led by Matchmaking services and higher EPS

99,902 Shares in AptarGroup, Inc. $ATR Acquired by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. has acquired 99,902 shares of AptarGroup, Inc. (NYSE:ATR) worth approximately $12.5 million, marking a new stake in the company. AptarGroup also reported strong quarterly earnings, exceeding expectations with $1.42 EPS and $1.03 billion in revenue, and declared a quarterly dividend …

VTRS Q2 Deep Dive: China Growth, Pipeline Progress, and Margin Concerns Shape Outlook

VTRS Q2 Deep Dive: China Growth, Pipeline Progress, and Margin Concerns Shape Outlook Medication company Viatris (NASDAQ:VTRS) announced better-than-expected revenue in Q2 CY2026, with sales up 4.9% year on year to $3.76 billion. The company expects the full year's revenue to be around $14.75 …

504,946 Shares in ATRenew Inc. Sponsored ADR $RERE Acquired by Renaissance Technologies LLC

Renaissance Technologies LLC acquired 504,946 shares of ATRenew Inc. Sponsored ADR (NYSE:RERE) during the first quarter, representing a 0.23% stake valued at approximately $2.37 million. This acquisition is part of broader institutional investment, with other firms also adjusting their positions in RERE. ATRenew recently …

Patrizia steigert Gewinn kräftig - Aktie legt zu

Dynatrace Says AI Workloads Fuel Observability Demand, Consumption Growth

Key Points Interested in Dynatrace, Inc.? Here are five stocks we like better. AI workloads are driving demand for observability as enterprises need end-to-end monitoring of AI performance, accuracy, security and outputs. Dynatrace says AI-related customers consume its platform at roughly 1.5 times the …

Viatris (VTRS) Stock Trades At A Discount To Sales Despite A 76% Run

Viatris (VTRS) stock has seen a 76.1% gain over the past year, yet remains undervalued according to various valuation checks, trading at a discount to sales compared to its industry peers. The recent FDA approval for Gwyn Lo contraceptive patch and the planned sale …

Truist cuts Patrick Industries stock price target on RV softness

Truist Securities has lowered its price target for Patrick Industries (NASDAQ:PATK) to $108 from $113, while maintaining a Buy rating, due to anticipated softness in the recreational vehicle market. The firm also reduced its adjusted EBITDA and EPS estimates for fiscal years 2026 and …

Patrick Industries (NASDAQ: PATK) files HSR notices in LCI merger plan

Patrick Industries (NASDAQ: PATK) has taken a procedural step in its previously announced merger with LCI Industries by filing Premerger Notification and Report Forms under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 on August 5, 2026. This filing with the Federal Trade Commission and …

AtriCure (ATRC) Lifted Its Guidance, Is The Stock Fully Priced?

AtriCure (ATRC) has seen insider share sales despite reporting 13% Q2 revenue growth, returning to net income, and raising full-year guidance. While one valuation narrative suggests the stock is 11.9% undervalued at $47.00 due to potential market expansion from clinical trials, another analysis using …

Why Dynatrace (DT) Is Up 9.9% After Mixed Q1, AI Launches, And Buyback Update

Harrow adds TYRVAYA's global rights to dry eye portfolio

Harrow is expanding its dry eye product portfolio by acquiring the global rights to TYRVAYA (varenicline solution) nasal spray from Viatris, Inc. This FDA-approved nasal spray, indicated for dry eye disease, was originally developed by Oyster Point Pharma. The deal involves a $30 million …